NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2014.
Connor-TH; MacKenzie-BA; DeBord-DG; Trout-DB; O'Callaghan-JP
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2014-138, 2014 Sep; :1-29
The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (https://www.cdc.gov/niosh/docs/2004-165/
). In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. The list was compiled from information provided by four institutions that have generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). The 2004 list was updated in 2010 and 2012. The current update (2014) adds 27 drugs and includes a review of the 2004 list and the consequent removal of 12 drugs that did not meet the NIOSH criteria for hazardous drugs. In addition, a new format has been developed for the list of hazardous drugs. The review process for the addition of the new listings is described in the Federal Register: https://www.cdc.gov/niosh/docket/review/docket233/pdf/CDC-2013-0007.pdf
Antineoplastic-agents; Pharmaceuticals; Health-care-personnel; Medical-personnel; Medical-treatment; Pharmaceutical-industry; Drugs; Hazardous-materials
NTIS Accession No.
(NIOSH) 2014-138; M092014
DART; DSHEFS; HELD
Healthcare and Social Assistance
National Institute for Occupational Safety and Health